This compound is a dimeric impurity of ibrutinib, a pharmaceutical reference standard used for quality control in drug manufacturing. It features a complex structure with multiple aromatic rings and heterocycles, reflecting its role as a process-related impurity in the synthesis of ibrutinib.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1288338-97-5
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-3-chloropropan-1-one
Pharmaceutical impurity reference standard
Risperidone Pyrimidinone-N-oxide
pharmaceutical reference standard impurity
1',4-Dihydroxy Midazolam
pharmaceutical reference standard impurity
Hydrocortisone EP Impurity I
pharmaceutical reference standard impurity
Erythromycin EP Impurity L
pharmaceutical reference standard impurity
Rimegepant
calcitonin gene-related peptide receptor antagonist
Warfarin sodium
active pharmaceutical ingredient
Ergonovine maleate
oxytocic active pharmaceutical ingredient
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-[(3S)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one
YVLRPRSHPNBRSQ-SZAHLOSFSA-N
C1C[C@@H](CN(C1)CCC(=O)N2CCC[C@H](C2)N3C4=NC=NC(=C4C(=N3)C5=CC=C(C=C5)OC6=CC=CC=C6)N)N7C8=NC=NC(=C8C(=N7)C9=CC=C(C=C9)OC1=CC=CC=C1)N
—